Skip to main content

Richard Y. Cheng

Member

Weaver Johnston Nelson, PLLC


I am a member/attorney at Weaver Johnston Nelson, PLLC serving exclusively in the healthcare and cannabis industries. My practice is focused on corporate transactions, healthcare regulations, administrative appeals, and healthcare compliance matters. I represent post-acute care providers (e.g. skilled nursing facilities, assisted living, hospices, home health agencies, rehabilitation providers), physician groups, management service organizations (MSOs), dental service organizations (DSOs), community hospitals, retail medicine providers (e.g. free standing ERs), ancillary providers (e.g. pharmacies, labs, DME), digital health companies, behavioral health, chiropractors, and veterinary practices, private equity groups and investors in the healthcare industry. 

Due to my healthcare practice, I regularly serve as special counsel in conjunction with white collar criminal defense teams in federal cases or investigations involving healthcare fraud and abuse. In these roles, I assist criminal defense attorneys on health care regulatory violations (e.g. Anti-kickback, OIG exclusion issues, etc.), operations, assessment of plea bargains and the sentencing process.

In addition to my healthcare practice, I developed a cannabis regulatory and corporate practice starting in late 2013. I formerly served as outside general counsel for the Texas Cannabis Industry Association, served on the National Cannabis Industry Association’s FDA coalition, which helped co-author a FDA primer in preparation for the 2019 FDA public hearing on CBD products, and currently serve as an advisory board member to a hemp bio-pharmaceutical development company. I represent and regularly advise a broad base of cannabis related clients, including, physicians, private equity groups investing in the cannabis industry, cultivators, processors, wholesalers, retailers, distribution centers, reverse distributors, and ancillary providers (e.g. testing labs, biomass brokerage firms, MLM companies etc.) in regulatory and corporate matters.

Product Type
On Demand

Hemp: USDA Interim Final Rule and What it Means for Hemp Clients


Average Rating:
   0
Categories:
Hemp Law |  Regulation law |  Hemp
Faculty:
Shawn Hauser |  Alex Berger |  Richard Y. Cheng |  Mai T. Dinh
Duration:
60 minutes
Format:
Audio and Video
SKU:
INCBA072420HEOD
License:
Access for 6 month(s) after purchase.
Short Description:
This panel seeks to get to the bottom of the IFR and what it means for the hemp CBD industry currently and in the future. We may also touch on the intersection of USDA and FDA authority to regulate h...
Price:
$75.00 - Non Member Price

Product Type
Live Event

Cannabis Law Institute 2023: Igniting Legal Excellence in the Cannabis Industry


Average Rating:
Not yet rated
Faculty:
Mary Shapiro, JD, MBA |  Shabnam Malek |  Fatima Afia |  Jason Horst |  Jessica C. McElfresh |  Zachary Kobrin |  Jason Moscovici |  Marie Sanchez |  ....
Duration:
51 Hours 50 Minutes
SKU:
incba06082023canlawinstLive
License:
Not Applicable
Short Description:
Cannabis Law Institute 2023
Price:
$1,099.00 - Non Member Price
Date:

Thu, Jun 08, 2023 - 09:00am to Sat, Jun 10, 2023 - 12:50pm PDT


Showing 1 to 2 of 2 entries